The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 21,501–21,600 of 31,469
Blood sugar levels are higher in obese young children in Sweden than in Poland
Hagman, E., Arani, P. I., Fischer, M., Danielsson, P., Marcinkiewicz, K., Petriczko, E., & Marcus, C. (2014) · Acta Paediatrica · doi:10.1111/apa.12760 · Cited by 9
Lewandowski, K. C., Stojanovic, N. D., Press, M., Tuck, S. M., Lewiñski, A., & Karbownik‐Lewińska, M. (2014) · Annals of Agricultural and Environmental Medicine · doi:10.5604/1232-1966.1108619 · Cited by 9
Chen, Y., Lee, Y. S., Wang, J., Jiang, Y.-Y., Li, H., An, Y., Hu, Y., Lee, K., & Li, G. (2011) · Pediatric Research · doi:10.1203/pdr.0b013e318225f8a9 · Cited by 10
Incretin responses to oral glucose load in Japanese non-obese healthy subjects
Nagai, E., Katsuno, T., Miyagawa, J., Konishi, K., Miuchi, M., Ochi, F., Kusunoki, Y., Tokuda, M., Murai, K., Hamaguchi, T., et al. (2011) · Diabetes Therapy · doi:10.1007/s13300-010-0017-1 · Cited by 9
Hemostatic factors in Australian Aboriginal and Torres Strait Islander populations
Wang, Z., Rowley, K., Best, J. D., McDermott, R. A., Taylor, M., & O’Dea, K. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.009 · Cited by 8
Omiya, K., Minami, K., Sato, Y., Takai, M., Takahashi, E., Hayashi, A., Yamauchi, M., Suzuki, K., Akashi, Y. J., Osada, N., et al. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.04.012 · Cited by 9
Hamada, N., Nishi, Y., Tajiri, Y., et al. (2012) · Circulation Journal · doi:10.1253/circj.cj-11-1345 · Cited by 9
Chang, R.-Y., Koo, M., Chen, C.-K., Lu, Y.-C., & Lin, Y.-F. (2013) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2011.0966 · Cited by 9
Oğuz, Y., Yılmaz, M. İ., Açıkel, C., Eyileten, T., Çağlar, K., Öktenli, Ç., Yenicesu, M., & Vural, A. (2009) · Renal Failure · doi:10.1080/08860220802546461 · Cited by 9
Abdominal obesity: causal factor or simply a symptom of obesity-related health risk
Oh, S., Tanaka, K., Noh, J., So, R., Tsujimoto, T., Sasai, H., Kim, M., & Shoda, J. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s64546 · Cited by 9
Tracer-determined glucose fluxes in health and type 2 diabetes: basal conditions
Radziuk, J., & Pye, S. (2003) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/s1521-690x(03)00038-1 · Cited by 9
Gender difference in adrenal sensitivity to ACTH is abolished in type 2 diabetes
Arnetz, L., Ekberg, N. R., Brismar, K., & Alvarsson, M. (2015) · Endocrine Connections · doi:10.1530/ec-15-0003 · Cited by 9
Study of insulin resistance in patients with systemic lupus erythematosus and rheumatoid arthritis
Elzorkany, K. M. A., Essa, E. S., Fayez, D., Gazareen, S., Dawood, A. A., & Elnajjar, M. M. (2014) · Menoufia Medical Journal · doi:10.4103/1110-2098.141634 · Cited by 9
Roemmler, J., Kuenkler, M., Otto, B., et al. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.07.001 · Cited by 9
Onat, A., Can, G., Çiçek, G., Doğan, Y., Kaya, H., Gümrükçüoğlu, H. A., & Yüksel, H. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.10.002 · Cited by 9
Relationship between Leptin Levels and Suppressed CD4 Counts in HIV Patients
Al-Fadhli, M., Saraya, M., Qasem, J., et al. (2012) · Medical Principles and Practice · doi:10.1159/000339201 · Cited by 9
Akehi, Y., Tsutsumi, Y., Tatsumoto, A., Yoshida, R., Ohkubo, K., Takenoshita, H., Kudo, T., Ashida, K., Anzai, K., Yamashita, T., et al. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-174 · Cited by 9
Thai, A. C., Mohan, V., Khalid, B. A. K., Cockram, C. S., Pan, C. Y., Zimmet, P., & Yeo, J. P. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.12.003 · Cited by 9
Al-attas, O., Hussain, T., Al-Daghri, N., Rosas, E. D., Kazmi, U., & Vinodson, B. (2013) · Journal of atherosclerosis and thrombosis · doi:10.5551/jat.14837 · Cited by 9
A low reported energy intake is associated with metabolic syndrome
Buscemi, S., Verga, S., Donatelli, M., D’Orio, L., Mattina, A., Tranchina, M. R., Pizzo, G., Mulè, G., & Cerasola, G. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346503 · Cited by 9
Simental‐Mendía, L. E., Rodríguez‐Morán, M., & Guerrero‐Romero, F. (2014) · Endocrine Research · doi:10.3109/07435800.2014.934963 · Cited by 9
de Luis, D. A., Aller, R., Jáuregui, O. I., Sagrado, M. G., Conde, R., Salvador, B. D. L. F., & Bobillo, E. R. (2009) · Metabolism · doi:10.1016/j.metabol.2009.09.004 · Cited by 9
Salman, S., Üzüm, A. K., Telci, A., Alagöl, F., & Özbey, N. (2011) · Pituitary · doi:10.1007/s11102-011-0332-1 · Cited by 9
Abdulla, M. H., Sattar, M. Z. A., Johns, E. J., et al. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0180-9 · Cited by 9
Gravante, G., Pomara, F., Angelomè, C., et al. (2001) · Acta Diabetologica · doi:10.1007/s005920170015 · Cited by 9
Risk factors for impaired glucose tolerance in obese children and adolescents
Kleber, M. (2010) · World Journal of Diabetes · doi:10.4239/wjd.v1.i4.129 · Cited by 9
Prieto, M. A. V., Renna, N. F., Lembo, C., et al. (2010) · Food & Function · doi:10.1039/c0fo00077a · Cited by 9
Fasting plasma ghrelin in women with and without PCOS
Kamal, M., Mohi, A., Fawzy, M., & Elsawah, H. (2010) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2010.04.006 · Cited by 9
Effect of glutamine on glucose metabolism in children with Duchenne muscular dystrophy
Letellier, G., Mok, É., Alberti, C., Luca, A. D., Gottrand, F., Cuisset, J., Denjean, A., Darmaun, D., & Hankard, R. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.08.019 · Cited by 9
Chen, Y., Qiao, J., Yan, L., Huang, S., Zhao, P.-L., & Yan, J. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.073 · Cited by 9
Kalra, L., Iveson, E., Rambaran, C., Sherwood, R. A., Chowienczyk, P., Ritter, J. M., Shah, A. M., & Forrester, T. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.10.013 · Cited by 9
Çekmez, F., Aydemir, G., Aydınöz, S., Pirgon, Ö., Genc, F. A., Tunç, T., & Sarıcı, S. Ü. (2012) · Cytokine · doi:10.1016/j.cyto.2012.04.031 · Cited by 9
Chang, R.-Y., Koo, M., Ho, M.-Y., Lin, Z.-Z., Yu, Z., Lin, Y.-F., & Wang, B.-J. (2010) · European Journal of Applied Physiology · doi:10.1007/s00421-010-1628-y · Cited by 9
Lim, S. K., Park, K. S., Kim, M., Cho, B. Y., & Lee, H. K. (2001) · Mitochondrion · doi:10.1016/s1567-7249(01)00003-4 · Cited by 9
Park, S., Sm, H., Lee, J., Sung, S., & Kim, S. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881106081529 · Cited by 9
Shin, J. S., & Huh, Y.-S. (2014) · Physical Activity and Nutrition · doi:10.5717/jenb.2014.18.1.41 · Cited by 9
Resistencia insulínica en pacientes pediátricos con fibrosis quística y sobrepeso
Jiménez, D. G., García, C. B., Crespo, M. F. R., et al. (2012) · Anales de Pediatría · doi:10.1016/j.anpedi.2011.11.016 · Cited by 9
Neves, F. J., Silva, B. M., Rocha, N. G., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328334f55c · Cited by 9
Evaluation of function and structure of arterial wall in girls and young women with Turner syndrome
Radetti, G., Mazzanti, L., Somma, C. D., Salerno, M. C., Gottardi, E., Capalbo, D., Tamburrino, F., & Colao, A. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0268-9 · Cited by 9
Tamayo, T., Jacobs, D. R., Straßburger, K., Giani, G., Seeman, T. E., Matthews, K. A., Roseman, J. M., & Rathmann, W. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9691-9 · Cited by 9
Addo, O. Y., Pereira, M. A., & Himes, J. H. (2012) · American Journal of Human Biology · doi:10.1002/ajhb.22321 · Cited by 9
Kishimoto, N., Okita, K., Takada, S., et al. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0381 · Cited by 9
Lai, J. Y., Atzmon, G., Melamed, M. L., Hostetter, T. H., Crandall, J. P., Barzilai, N., & Bitzer, M. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03902.x · Cited by 9
Cervical lipomatosis in HIV‐infected patients: a case–control study
Palacios, R., Galindo, M., Arranz, J., et al. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00421.x · Cited by 9
Tassone, F., Gianotti, L., Rolfo, F., Visconti, G., Borretta, G., & Feola, M. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345749 · Cited by 9
Román, R., Íñiguez, G., Salazar, T., et al. (2008) · Hormone Research in Paediatrics · doi:10.1159/000139147 · Cited by 9
Kokavec, A. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.02.022 · Cited by 9
Polovina, S. P., & Micić, D. (2010) · Medicinski pregled · doi:10.2298/mpns1008465p · Cited by 9
Potential antidiabetic effect of the Semecarpus anacardium in a type 2 diabetic rat model
Khan, H. B. H., Vinayagam, K. S., Renny, C. M., Shanthi, P., & Panchanadham, S. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0136-6 · Cited by 9
Pijl, H., Cohen, A. F., Verkes, R. J., et al. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00043-7 · Cited by 9
de Luis, D. A., Sagrado, M. G., Aller, R., Izaola, O., Conde, R., & Romero, E. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.283 · Cited by 9
Soydan, A. S., Dökmetaş, H. S., Cetin, M., Koyuncu, A., Kaptanoglu, E., & Elden, H. (2006) · Mediators of Inflammation · doi:10.1155/mi/2006/64980 · Cited by 9
Hettihewa, L. M., & Weerarathna, T. P. (2011) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.83280 · Cited by 12
Kamezaki, F., Sonoda, S., Nakata, S., Kashiyama, K., Muraoka, Y., Okazaki, M., Tamura, M., Abe, H., Takeuchi, M., & Otsuji, Y. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.7235 · Cited by 9
Miljkovic, I., Cauley, J. A., Dressen, A., Gordon, C. L., Goodpaster, B. H., Kuller, L. H., Bunker, C. H., Patrick, A. L., Wheeler, V. W., ORWOLL, E. S., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.014 · Cited by 9
Shin, J. Y., Choi, Y. H., & Song, Y. M. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1073752 · Cited by 9
Chae, H. B., Lee, S. Y., Kim, N. H., et al. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.3.312 · Cited by 9
Liu, C.-Y., Hsu, Y.-J., Chien, Y., Cha, T.-L., & Tsao, C. (2015) · Andrologia · doi:10.1111/and.12454 · Cited by 9
Boulhosa, R. S. S. B., de Oliveira, L. P. M., de Jesús, R. P., Cavalcante, L. N., Lemaire, D. C., Vinhas, L., Lyra, L. G. C., & Lyra, A. C. (2013) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12087 · Cited by 9
Postprandial plasma adiponectin response is reduced in prepubertal premature pubarche girls
Larqué, E., Gil‐Campos, M., Villada, I., Ramírez-Tortosa, M. C., Cañete, R., & Gil, Á. (2010) · Metabolism · doi:10.1016/j.metabol.2009.12.009 · Cited by 9
Günther, A. L. B., Schulze, M. B., Kroke, A., Diethelm, K., Joslowski, G., Krupp, D., Wudy, S. A., & Buyken, A. E. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1056313 · Cited by 10
Long-term effects of radiotherapy on cardiovascular risk factors in acromegaly
Ronchi, C. L., Verrua, E., Ferrante, E., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1105 · Cited by 9
Kelishadi, R., Nilforoushan, N., Okhovat, A., Amra, B., Poursafa, P., & Rogha, M. (2011) · Europe PMC (PubMed Central) · Cited by 9
Chistiakov, D. A., Ходырев, Д. С., Smetanina, S. A., et al. (2010) · The Review of Diabetic Studies · doi:10.1900/rds.2010.7.285 · Cited by 9
Thomaseth, K., Brehm, A., Pavan, A., Pacini, G., & Roden, M. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00314.2013 · Cited by 9
Alteration in fasting glucose after prolonged treatment with a thiazide diuretic
Karnes, J. H., Gong, Y., Arwood, M. J., Gums, J. G., Hall, K., Limacher, M. C., Johnson, J. A., & Cooper‐DeHoff, R. M. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.004 · Cited by 9
López Caudana, A. E., López Ridaura, R., González Villalpando, C., Lazcano Ponce, E. C., Casanueva y López, E. M., Hernández Ávila, M., & Téllez-Rojo Solís, M. M. (2011) · Archives of Medical Research · doi:10.1016/j.arcmed.2011.01.010 · Cited by 9
Kyrgios, I., Galli‐Τsinopoulou, A., & Stylianou, C. (2013) · Regulatory Peptides · doi:10.1016/j.regpep.2013.03.022 · Cited by 9
Therapeutic response to metformin in an underweight patient with polycystic ovarian syndrome
Al‐Ozairi, E., Quinton, R., & Advani, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.041 · Cited by 9
Testosterone Deficiency Associated with Poor Glycemic Control in Korean Male Diabetics
Kim, J., Kim, B. S., Jeon, J. Y., Choi, Y. J., & Chung, Y. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.3.300 · Cited by 9
Francisco, G., Hernández, C., Galard, R., & Simó, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031883 · Cited by 9
Changes in transferrin are related to changes in insulin resistance: the SLIM study
Roumen, C., Feskens, E. J. M., Jansen, E., et al. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02589.x · Cited by 9
Hung, C.-C., Liao, C.-C., Wu, P.-L., Lee, S., & Lane, H. (2014) · Biomedicine · doi:10.7603/s40681-014-0006-1 · Cited by 9
Doh, F. M., Chang, T. I., Koo, H. M., et al. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6412-2 · Cited by 9
Doyon, C., Samson, P., Lalonde, J., & Richard, D. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07064 · Cited by 9
Risk of Metabolic Syndrome and Diabetes Among Young Twins and Singletons in Guinea-Bissau
Bjerregaard-Andersen, M., Hansen, L., da Silva, L. I., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2653 · Cited by 9
Cioni, A., Sordini, C., Cavallini, I., Bigazzi, R., & Campese, V. M. (2010) · Peritoneal Dialysis International · doi:10.3747/pdi.2008.00155 · Cited by 9
Koopal, C., van der Graaf, Y., Asselbergs, F. W., Westerink, J., & Visseren, F. L. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.015 · Cited by 10
Longer HSD11B2 CA-repeat in impaired glucose tolerance and type 2 diabetes
Mune, T., Suwa, T., Morita, H., Isomura, Y., Takada, N., Yamamoto, Y., Hayashi, M., Yamakita, N., Sasaki, A., Takeda, N., et al. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej12-0108 · Cited by 9
Trovato, G. M., Martines, G. F., Trovato, F. M., et al. (2011) · Endocrine Research · doi:10.3109/07435800.2011.625513 · Cited by 9
Wang, J., Zhang, Y., Yang, Z., Zhu, T., Wang, L., Chen, B., Cao, K., Huang, J., Ma, W., & Jia, E. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00798.x · Cited by 9
de Luis, D. A., Sagrado, M. G., Aller, R., Izaola, O., Conde, R., & de la Fuente, B. (2010) · PubMed · Cited by 9
INSULIN RESISTANCE AND SERUM PARAMETERS OF IRON STATUS IN TYPE 2 DIABETICS
Zafar, U., Qureshi, H. J., & Karim, A. (2011) · Pakistan Journal of Physiology · Cited by 9
Bekdaş, M., Kaya, E., Dağıstan, E., Göksügür, S. B., Demircioğlu, F., Erkoçoğlu, M., & Dilek, M. (2015) · Pediatric Obesity · doi:10.1111/ijpo.12096 · Cited by 9
Fatty liver in adults receiving antiepileptic medications: relationship to the metabolic risks
Hamed, S. A., Abd-Elaal, R. F., Radwan, M. E. M., & Abdellah, M. M. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1131123 · Cited by 9
Blood Pressure in Adolescence, Adipokines and Inflammation in Young Adults. The Rio de Janeiro Study
Campana, É. M. G., Brandão, A. A., Pozzan, R., et al. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130226 · Cited by 9
Salto, L., Bu, L., Beeson, W. L., Firek, A. F., Cordero‐MacIntyre, Z., & León, M. A. D. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13010052 · Cited by 9
Low serum levels of ghrelin are associated with gallstone disease
Méndez-Sánchez, N. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i19.3096 · Cited by 9
Maternal circulating levels of irisin in intrahepatic cholestasis of pregnancy
Kırbaş, A., Dağlar, K., Tımur, H., Biberoglu, E. H., İnal, H. A., Kara, Ö., Yilmaz, Z., Türkmen, G. G., & Danışman, N. (2015) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2015.1132694 · Cited by 9
Abo‐Youssef, A. M. (2015) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.169577 · Cited by 9
Buko, V., Zavodnik, I. B., Lukivskaya, O., Naruta, E. E., Palecz, B., Belica, S., Belonovskaya, E., Kranc, R., & Abakumov, V. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.014 · Cited by 9
Iron Status and Metabolic Syndrome in Patients with Non-Alcoholic Fatty Liver Disease
Ghamarchehreh, M. E., Jafari, N. J., Bigdeli, M., Khedmat, H., & Saburi, A. (2015) · Middle East Journal of Digestive Diseases · doi:10.15171/mejdd.2016.04 · Cited by 9
Gohlke, B. C., Stutte, S., Bartmann, P., & Woelfle, J. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.9.827 · Cited by 9
Indices of insulin resistance in paediatric obesity
Chandrasekhar, T., Suchitra, M. M., Sachan, A., Bitla, A. R. R., & Rao, P. (2014) · The Journal of Clinical and Scientific Research · doi:10.15380/2277-5706.jcsr.13.012 · Cited by 9
Góes, S. M., Stefanello, J. M. F., Homann, D., Lodovico, A., Hubley‐Kozey, C. L., & Rodacki, A. L. F. (2016) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000001395 · Cited by 9
Relationship between insulin resistance and tissue blood flow in preeclampsia
Anim‐Nyame, N., Gamble, J., Sooranna, S. R., Johnson, M. R., & Steer, P. J. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000494 · Cited by 9
Alghadir, A. H., Gabr, S. A., & Al-Eisa, E. S. (2016) · Journal of Physical Therapy Science · doi:10.1589/jpts.28.1092 · Cited by 10
Cao, L., Graham, S. L., & Pilowsky, P. M. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00486.2015 · Cited by 9
Ovaries are more vulnerable than hepatocytes for insulin resistance and hyperinsulinemia
Gültepe, İ., Başaranoğlu, M., Süleymanoğlu, Y., Başaranoğlu, G., & Beyazıt, F. (2016) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2015.150473 · Cited by 9
Radika, M. K., & Anuradha, C. V. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2014-0122 · Cited by 9
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
